CA2083735A1 - Derives de substitution en n de 1,2,4-triazolone, utiles pour le traitement des troubles cardiovasculaires - Google Patents

Derives de substitution en n de 1,2,4-triazolone, utiles pour le traitement des troubles cardiovasculaires

Info

Publication number
CA2083735A1
CA2083735A1 CA002083735A CA2083735A CA2083735A1 CA 2083735 A1 CA2083735 A1 CA 2083735A1 CA 002083735 A CA002083735 A CA 002083735A CA 2083735 A CA2083735 A CA 2083735A CA 2083735 A1 CA2083735 A1 CA 2083735A1
Authority
CA
Canada
Prior art keywords
butyl
biphenyl
dihydro
ylmethyl
tetrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002083735A
Other languages
English (en)
Inventor
Robert E. Manning
David B. Reitz
Horng-Chih Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2083735A1 publication Critical patent/CA2083735A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002083735A 1990-05-25 1991-05-23 Derives de substitution en n de 1,2,4-triazolone, utiles pour le traitement des troubles cardiovasculaires Abandoned CA2083735A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52907990A 1990-05-25 1990-05-25
US529,079 1990-05-25

Publications (1)

Publication Number Publication Date
CA2083735A1 true CA2083735A1 (fr) 1991-11-26

Family

ID=24108443

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002083735A Abandoned CA2083735A1 (fr) 1990-05-25 1991-05-23 Derives de substitution en n de 1,2,4-triazolone, utiles pour le traitement des troubles cardiovasculaires

Country Status (5)

Country Link
EP (1) EP0531382A1 (fr)
JP (1) JPH05506443A (fr)
AU (1) AU7903091A (fr)
CA (1) CA2083735A1 (fr)
WO (1) WO1991018888A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411980A (en) * 1989-07-28 1995-05-02 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
JP3290657B2 (ja) * 1991-05-01 2002-06-10 メルク エンド カムパニー インコーポレーテッド アンギオテンシンｉｉ拮抗剤として活性な酸性アラルキルトリアゾール誘導体
JP3890453B2 (ja) * 1996-09-18 2007-03-07 リードケミカル株式会社 新規２，４−ジオキソピロリジンおよび２，４−ジオキソテトラヒドロフラン誘導体及び該化合物を有効成分とする医薬
GB9716446D0 (en) * 1997-08-05 1997-10-08 Agrevo Uk Ltd Fungicides
EP1044958A4 (fr) 1997-11-14 2004-11-17 Sumitomo Chemical Co PROCEDE DE PRODUCTION DE tert-BUTYL 4'-METHYL-2-BIPHENYLCARBOXYLATE
HUP0100178A3 (en) * 1997-12-17 2002-12-28 Merck & Co Inc Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (fr) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151206A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
EP0412594B1 (fr) * 1989-07-28 1996-01-03 Merck & Co. Inc. Triazolinones, triazolinethiones et triazolinimines substituées comme antagonistes d'angiotensine II

Also Published As

Publication number Publication date
EP0531382A1 (fr) 1993-03-17
JPH05506443A (ja) 1993-09-22
AU7903091A (en) 1991-12-31
WO1991018888A1 (fr) 1991-12-12

Similar Documents

Publication Publication Date Title
US5087634A (en) N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5401764A (en) Benzimidazole derivative compositions and medical use thereof
CA2083735A1 (fr) Derives de substitution en n de 1,2,4-triazolone, utiles pour le traitement des troubles cardiovasculaires
Carini et al. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl) imidazoles as potent, orally active antihypertensives
US5098920A (en) 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
CA2141692C (fr) Promedicaments d'acides carboxyles d'imidazole comme antagonistes des recepteurs de l'angiotensine ii
HU218461B (hu) Szubsztituált imidazolszármazékok, és hatóanyagként e vegyületeket tartalmazó gyógyszerkészítmények
WO1992016523A1 (fr) Composes de 5-arylheteroarylalkyle-1,3,5_trisubstitue-1,2,4-triazole pour le traitement de maladies circulatoires
US20010020100A1 (en) N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders
US5187271A (en) N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
IE913038A1 (en) Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole¹angiotensin ii antagonists for treatment of hypertension
US5563139A (en) Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a glaucoma disorder
US5140036A (en) 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
JPH08508249A (ja) 循環系疾患の治療のための１−フェニル−イミダゾール−２−オンビフェニルメチル化合物
US5451597A (en) Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists
US5294617A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
Huang et al. Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists
US6008368A (en) Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists
US5484937A (en) N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders
US5175180A (en) N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds and use for treatment of circulatory disorders
US5238952A (en) N-substituted imidazol-2-one compounds for treatment of circulatory disorders
IE911801A1 (en) N-substituted-1,2,4-triazolone compounds for treatment of¹cardiovascular disorders
US5229406A (en) 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US20040121989A1 (en) Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension
PT97861A (pt) Processo para a preparacao de compostos 1,2,4-triazolona n-substituidas para o tratamento de doencas cardiovasculares

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19941123